Moderna ‘committed to transparency,’ highlights research on COVID-19 vaccine

Moderna (MRNA) has added a new statement to its website, in which the company stated: “Moderna is committed to transparency and welcomes the opportunity to highlight the extensive research regarding our COVID-19 vaccine, which has been published in hundreds of peer-reviewed publications and shared with regulators. Moderna is a research-driven, American company and we are immensely proud of the role we played in the historic achievements of Operation Warp Speed. As President Trump said at the time, ‘we are the most exceptional nation in the history of the world… American companies were the first to produce a verifiably safe and effective vaccine.’ These vaccines helped end the COVID-19 pandemic, re-open economies and save millions of lives. Since 2021, the real-world effectiveness and safety of the vaccines have been confirmed by governments and health systems around the world. Moderna itself has conducted vaccine effectiveness studies every year, in more than 5 million people to-date. These studies consistently show that the Moderna COVID-19 vaccine confers a high degree of protection against hospitalizations among the most vulnerable. We have also actively monitored the safety of the more than one billion doses administered to-date, and have always transparently shared those results with regulators and with the public, including through peer-reviewed publications and presentations. We will continue to do so as part of our commitment to transparency. The promise of mRNA is immense. The same technology that helped turn the tide of a global pandemic is now paving the way for breakthroughs in cancer, autoimmune and rare diseases. To help ensure Americans have clear and accessible information, Moderna will be compiling previously disclosed information on our website throughout the day.”